About: A Virtual Standardized Patient–Based Assessment Tool to Evaluate Psychiatric Residents’ Psychopharmacology Proficiency

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: A Virtual Standardized Patient–Based Assessment Tool to Evaluate Psychiatric Residents’ Psychopharmacology Proficiency Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	A Virtual Standardized Patient–Based Assessment Tool to Evaluate Psychiatric Residents’ Psychopharmacology Proficiency
Creator	Talbot, Thomas Rakofsky, Jeffrey Dunlop, Boadie
Source	Medline; PMC
abstract	OBJECTIVES: A virtual standardized patient-based assessment simulator was developed to address biases and practical limitations in existing methods for evaluating residents’ proficiency in psychopharmacological knowledge and practice. METHODS: The simulator was designed to replicate an outpatient psychiatric clinic experience. The virtual patient reported symptoms of a treatment-resistant form of major depressive disorder (MDD), requiring the learner to use various antidepressants in order for the patient to fully remit. Test scores were based on the proportion of correct responses to questions asked by the virtual patient about possible side effects, dosing, and titration decisions, which depended upon the patient’s tolerability and response to the learner’s selected medications. The validation paradigm included a novice-expert performance comparison across 4th year medical students, psychiatric residents from all four post-graduate year classes, and psychiatry department faculty, and a correlational analysis of simulator performance with the PRITE Somatic Treatments subscale score. Post-test surveys evaluated the test takers’ subjective impressions of the simulator. RESULTS: Forty-three subjects completed the online exam and survey. Total mean scores on the exam differed significantly across all the learner groups in a step-wise manner from students to faculty (F = 6.10, p = 0.0001). Total mean scores by residency class correlated with PRITE Somatic Therapies subscale scores (p < 0.01). The post-test survey mean Likert results ranged from 3.33 ± 1.20 to 4.4 ± 0.79, indicating neutral to favorable responses for use of the simulator. CONCLUSIONS: This simulator demonstrated strong construct validity and high participant acceptability for assessing proficiency in the psychopharmacologic treatment of MDD.
has issue date	2020-07-17(xsd:dateTime)
bibo:doi	10.1007/s40596-020-01286-x
bibo:pmid	32681418
has license	no-cc
sha1sum (hex)	a29255f98c17499eceefc7e88af7c561eae03a41
schema:url	https://doi.org/10.1007/s40596-020-01286-x
resource representing a document's title	A Virtual Standardized Patient–Based Assessment Tool to Evaluate Psychiatric Residents’ Psychopharmacology Proficiency
has PubMed Central identifier	PMC7367158
has PubMed identifier	32681418
schema:publication	Acad Psychiatry
resource representing a document's body	covid:a29255f98c17499eceefc7e88af7c561eae03a41#body_text
is schema:about of	named entity 'Results' named entity 'survey' named entity 'virtual' named entity 'neutral' named entity 'medical students' named entity 'score' named entity 'tolerability' named entity 'performance' named entity 'Proficiency' covid:arg/a29255f98c17499eceefc7e88af7c561eae03a41 named entity 'existing' named entity 'subjective' named entity 'major depressive disorder (MDD)' named entity 'residents' named entity 'Test' named entity 'scores' named entity 'treatment-resistant' named entity 'faculty' named entity 'residents' named entity 'Standardized' named entity 'post-graduate' named entity 'MDD' named entity 'MDD' named entity 'standardized patient' named entity '0.01' named entity 'Standardized Patient' named entity 'Psychopharmacology' named entity 'Assessment Tool' named entity 'ear buds' named entity 'treatment algorithm' named entity 'medical students' named entity 'treatment options' named entity 'major depression' named entity '1.2' named entity 'psychiatric disorders' named entity 'STAR*D' named entity 'psychopharmacology' named entity 'pertain' named entity 'psychopharmacologic' named entity 'construct validity' named entity 'antidepressant' named entity 'psychotropics' named entity 'psychopharmacology' named entity 'psychopharmacology' named entity 'standardized test' named entity 'pharmacologic' named entity 'statistically significant' named entity 'psychiatry' named entity 'PGY' named entity 'medical students' named entity 'psychotropic medications' named entity 'virtual patient' named entity 'lithium' named entity 'Likert scale' named entity 'ANOVA' named entity 'medical education' named entity 'PGY-1' named entity 'Attending physicians' named entity 'voice communication' named entity 'psychopharmacology' named entity 'survey data' named entity 'antidepressant' named entity 'e-mail' named entity 'attendings' named entity 'residency program' named entity 'standard deviations' named entity 'Psychiatry' named entity 'general psychiatry' named entity '3.8' named entity 'outpatient' named entity 'mood disorders' named entity 'standardized patient' named entity 'mirtazapine' named entity 'psychopharmacology' named entity 'psychopharmacology' named entity 'PGY-1' named entity '4.3' named entity 'outpatient' named entity '17.1'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software